EN
0
Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > (S)-6-AMINO-N-((S)-1-(((S)-1-AMINO-4-METHYL-1-OXOPENTAN-2-YL)AMINO)-1-OXOPROPAN-2-YL)-2-((5S,8S,11S,14S,17S,23S,26S,29S,35S,38S,41S,44S,47S,50S,53S)-5-(2-AMINOACETAMIDO)-14,35,44-TRIS(4-AMINOBUTYL)-26,38-DI((S)-SEC-BUTYL)-11-(HYDROXYMETHYL)-53-ISOBUTYL-47
(S)-6-AMINO-N-((S)-1-(((S)-1-AMINO-4-METHYL-1-OXOPENTAN-2-YL)AMINO)-1-OXOPROPAN-2-YL)-2-((5S,8S,11S,14S,17S,23S,26S,29S,35S,38S,41S,44S,47S,50S,53S)-5-(2-AMINOACETAMIDO)-14,35,44-TRIS(4-AMINOBUTYL)-26,38-DI((S)-SEC-BUTYL)-11-(HYDROXYMETHYL)-53-ISOBUTYL-47 structure, CAS 102068-15-5

(S)-6-AMINO-N-((S)-1-(((S)-1-AMINO-4-METHYL-1-OXOPENTAN-2-YL)AMINO)-1-OXOPROPAN-2-YL)-2-((5S,8S,11S,14S,17S,23S,26S,29S,35S,38S,41S,44S,47S,50S,53S)-5-(2-AMINOACETAMIDO)-14,35,44-TRIS(4-AMINOBUTYL)-26,38-DI((S)-SEC-BUTYL)-11-(HYDROXYMETHYL)-53-ISOBUTYL-47

CAS Number102068-15-5

SynonymsPGLa

Molecular FormulaC88H162N26O22S

Molecular Weight1968.45000

Purity96+%

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS0

MSDSChineseEnglish

Symboltransportation

Signal WordWarning

Cat. No.: 2A-0101822 Purity: 96+%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 102068-15-5 ] Purity: 96+% SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number102068-15-5
Catalog No.2A-0101822
Chinese NamePGLA
SynonymsPGLa
Molecular FormulaC88H162N26O22S
Molecular Weight1968.45000
Purity96+
ApplicationPGLa is an antimicrobial peptide that has bacteriostatic effects on both Gram-positive and Gram-negative bacteria.
EINECS0
HTC0
UN(IATA)0
PubChem ID15363275
SMILESCCC(C)C(NC(=O)C(C)NC(=O)CNC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)CN)C(=O)NC(C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC(C)C)C(N)=O)C(C)C)C(C)CC
InChIInChI=1S/C88H162N26O22S/c1-19-48(9)69(113-78(126)52(13)97-66(117)42-95-72(120)50(11)98-79(127)59(31-23-27-36-91)108-85(133)64(44-115)111-77(125)54(15)100-81(129)61(33-38-137-18)104-65(116)41-93)87(135)101-51(12)73(121)96-43-67(118)105-57(29-21-25-34-89)82(130)114-70(49(10)20-2)88(136)103-55(16)74(122)106-60(32-24-28-37-92)83(131)112-68(47(7)8)86(134)102-56(17)76(124)110-63(40-46(5)6)84(132)107-58(30-22-26-35-90)80(128)99-53(14)75(123)109-62(71(94)119)39-45(3)4/h45-64,68-70,115H,19-44,89-93H2,1-18H3,(H2,94,119)(H,95,120)(H,96,121)(H,97,117)(H,98,127)(H,99,128)(H,100,129)(H,101,135)(H,102,134)(H,103,136)(H,104,116)(H,105,118)(H,106,122)(H,107,132)(H,108,133)(H,109,123)(H,110,124)(H,111,125)(H,112,131)(H,113,126)(H,114,130)/t48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,68-,69-,70-/m0/s1
InChI KeyPJRSUKFWFKUDTH-UHFFFAOYSA-N
Hazard Symbolstransportation
MSDSmsds/101822_2_102068_15_5.pdf
BioactivityPGLa is an antimicrobial peptide. PGLa is known to be bacteriostatic against both Gram-positive and Gram-negative bacteria. Related Catalog Signaling Pathways >> Anti-infection >> Bacterial Research Areas >> Infection Peptides Target Anti-bacteria[1] In Vitro PGLa is known to be bacteriostatic against both Gram-positive and Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa, Streptococcus pyogenes, and Staphylococcus aureus), without much selectivity between the two types of bacterial cells. PGLa is synthesized as a native (the wild type) peptide and as a mutant with a norleucine instead of methionine at position 2Met (designated PGLa(Nle)). References [1]. Radchenko DS, et al. Does a methionine-to-norleucine substitution in PGLa influence peptide-membrane interactions? Biochim Biophys Acta. 2016 Sep;1858(9):2019-27. Chemical & Physical Properties Molecular Formula C88H162N26O22S Molecular Weight 1968.45000 Exact Mass 1967.21000 PSA 800.72000 LogP 4.65010 InChIKey PJRSUKFWFKUDTH-UHFFFAOYSA-N SMILES CCC(C)C(NC(=O)C(C)NC(=O)CNC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)CN)C(=O)NC(C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC(C)C)C(N)=O)C(C)C)C(C)CC
Use ofPGLa is an antimicrobial peptide. PGLa is known to be bacteriostatic against both Gram-positive and Gram-negative bacteria. Properties Articles27 Name gly-met-ala-ser-lys-ala-gly-ala-ile-ala-gly-lys-ile-ala-lys-val-ala-leu-lys-ala-leu-nh2 Synonym More Synonyms PGLa Biological Activity Description PGLa is an antimicrobial peptide. PGLa is known to be bacteriostatic against both Gram-positive and Gram-negative bacteria. Related Catalog Signaling Pathways >> Anti-infection >> Bacterial Research Areas >> Infection Anti-bacteria[1] In Vitro PGLa is known to be bacteriostatic against both Gram-positive and Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa, Streptococcus pyogenes, and Staphylococcus aureus), without much selectivity between the two types of bacterial cells. PGLa is synthesized as a native (the wild type) peptide and as a mutant with a norleucine instead of methionine at position 2Met (designated PGLa(Nle)). References [1]. Radchenko DS, et al. Does a methionine-to-norleucine substitution in PGLa influence peptide-membrane interactions? Biochim Biophys Acta. 2016 Sep;1858(9):2019-27. Chemical & Physical Properties Molecular Formula C88H162N26O22S Exact Mass 1967.21000 PSA 800.72000 LogP 4.65010 InChIKey PJRSUKFWFKUDTH-UHFFFAOYSA-N SMILES CCC(C)C(NC(=O)C(C)NC(=O)CNC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)CN)C(=O)NC(C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC(C)C)C(N)=O)C(C)C)C(C)CC
Transport InfoProduct name: Purity: 98.0%
MSDS Transport InfoModule 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available
Related Products in Pharmaceutical Intermediates
(S)-6-(3-METHYLPIPERAZIN-1-YL)NICOTINONITRILE1057682-03-72A-0101814
(S)-6-(CHLOROMETHYL)-5,6-DIHYDRO-2H-PYRAN-2-ONE135999-61-02A-0101816
(S)-6-(HYDROXYMETHYL)-1,6-DIMETHYL-6,7,8,9-TETRAHYDROPHENANTHRO[1,2-B]FURAN-10,11-DIONE17397-93-22A-0101817
(S)-6-(HYDROXYMETHYL)PIPERIDIN-2-ONE128726-47-62A-0101818
(S)-6-AMINO-2-(4-METHYLPHENYLSULFONAMIDO)HEXANOIC ACID16948-09-72A-0101821
(S)-6-BROMO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE176707-78-12A-0101824
(S)-6-CHLORO-4-HYDROXY-3,4-DIHYDRO-2H-THIENO[3,2-E][1,2]THIAZINE 1,1-DIOXIDE160982-16-12A-0101825
(S)-6-FLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE HYDROCHLORIDE173996-44-62A-0101826
(S)-6-FLUOROCHROMAN-4-AMINE HYDROCHLORIDE1260609-97-92A-0101828
(S)-6-METHOXY-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE177017-69-52A-0101830
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA